IRIS
1.5 Abstract in rivista
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 14.198
NA - Nord America 2.632
EU - Europa 1.604
OC - Oceania 66
AF - Africa 50
SA - Sud America 50
Totale 18.600
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 11.736
US - Stati Uniti d'America 2.500
HK - Hong Kong 1.185
CN - Cina 882
GB - Regno Unito 541
IT - Italia 405
DE - Germania 211
IN - India 188
CA - Canada 104
NL - Olanda 85
AU - Australia 57
EE - Estonia 54
FI - Finlandia 53
CZ - Repubblica Ceca 52
TR - Turchia 45
FR - Francia 32
UA - Ucraina 32
JP - Giappone 30
PL - Polonia 25
BR - Brasile 24
MX - Messico 24
ES - Italia 23
AE - Emirati Arabi Uniti 17
ID - Indonesia 16
ZA - Sudafrica 16
TW - Taiwan 14
EG - Egitto 13
SA - Arabia Saudita 11
SE - Svezia 11
AR - Argentina 10
PK - Pakistan 10
IE - Irlanda 9
AT - Austria 8
BD - Bangladesh 8
CH - Svizzera 8
CL - Cile 8
ET - Etiopia 8
MY - Malesia 7
RU - Federazione Russa 7
DK - Danimarca 6
IL - Israele 6
KR - Corea 6
NG - Nigeria 5
NZ - Nuova Zelanda 5
PH - Filippine 5
PT - Portogallo 5
RO - Romania 5
SK - Slovacchia (Repubblica Slovacca) 5
VN - Vietnam 5
HU - Ungheria 4
LT - Lituania 4
NP - Nepal 4
CO - Colombia 3
EC - Ecuador 3
GH - Ghana 3
GR - Grecia 3
IR - Iran 3
KW - Kuwait 3
KZ - Kazakistan 3
LK - Sri Lanka 3
SI - Slovenia 3
AZ - Azerbaigian 2
BE - Belgio 2
CU - Cuba 2
LV - Lettonia 2
MK - Macedonia 2
OM - Oman 2
PG - Papua Nuova Guinea 2
PS - Palestinian Territory 2
AL - Albania 1
BO - Bolivia 1
CD - Congo 1
HR - Croazia 1
IS - Islanda 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MA - Marocco 1
MD - Moldavia 1
MM - Myanmar 1
MS - Montserrat 1
NO - Norvegia 1
PE - Perù 1
RE - Reunion 1
RS - Serbia 1
SN - Senegal 1
TH - Thailandia 1
TO - Tonga 1
TV - Tuvalu 1
UG - Uganda 1
Totale 18.600
Salva come PNG Salva come JPEG
Città #
Hong Kong 1.165
Singapore 991
Ashburn 753
Boardman 582
Hefei 498
London 458
Shanghai 344
Los Angeles 130
San Francisco 114
Pune 110
Rome 97
West Jordan 90
Council Bluffs 70
Munich 67
Washington 60
Amsterdam 59
Toronto 53
Seattle 43
Brno 40
Milan 39
Santa Clara 37
Sona 36
Turku 32
Brooklyn 24
New York 23
Chicago 22
Helsinki 21
Warsaw 20
Canberra 18
Hanover 18
Melbourne 18
Tokyo 18
Mexico City 16
Montreal 15
São Paulo 14
Central 13
Paris 13
Chennai 11
Riyadh 11
Sydney 11
Glasgow 10
Olomouc 10
Berlin 9
Charlotte 9
Andover 8
Istanbul 8
Manchester 8
Naples 8
Secaucus 8
Stockholm 8
Boston 7
Brescia 7
Buffalo 7
Dublin 7
Oklahoma City 7
Phoenix 7
Redmond 7
Addis Ababa 6
Arlington 6
Bologna 6
Dallas 6
Pittsburgh 6
Ankara 5
Auckland 5
Beitou 5
Bengaluru 5
Bratislava 5
Cairo 5
Catania 5
Copenhagen 5
Dubai 5
Gazoldo degli Ippoliti 5
New Delhi 5
San Diego 5
Sittard 5
Tallinn 5
Vancouver 5
Vienna 5
Atlanta 4
Budapest 4
Florence 4
Genoa 4
Johannesburg 4
Kathmandu 4
Markham 4
Opera 4
Taipei 4
Treviglio 4
Accra 3
Aprilia 3
Boydton 3
Calgary 3
Campbell River 3
Clifton 3
Haikou 3
Hangzhou 3
Helena 3
Hyderabad 3
Jersey City 3
Juneau 3
Totale 6.475
Salva come PNG Salva come JPEG
Nome #
NEW TECHNOLOGIES IN RADIOTHERAPY FOR PROSTATE CANCER: FEASIBILITY, DOSIMETRIC ASPECTS AND CLINICAL RESULTS IN PATIENTS WITH AT LEAST 5-YEAR FOLLOW-UP 220
18F-Choline PET/CT for early detection of prostate cancer recurrence after radical prostatectomy 219
Effect of hypothermia on human colonic smooth muscle contractility 204
Abstract 486: MicroRNA-30 family members inhibit breast cancer invasion, osteomimicry, and bone destruction by directly targeting multiple bone metastasis-associated genes 201
1338P TP53 truncating and missense mutations are linked to differential response to checkpoint blockade in patients with advanced non-small cell lung cancer (NSCLC) 200
A new adjunct for emergency airway management:the Laryngeal Tube, preliminary data 198
Purse-String Closure vs Conventional Direct Closure of Wounds after Stoma Reversal: A Prospective Randomized Controlled Study 195
69P Dose-dependent detrimental effect of proton pump inhibitors (PPIs) on clinical outcomes from immune checkpoint inhibitors (ICI) in patients (pts) with solid tumors 194
96P Induction chemotherapy backbone in frail patients (pts) with advanced NSCLC treated with chemotherapy plus pembrolizumab (P): A single institution retrospective audit of dose intensities from modified regimens 191
A biomechanical index for the evaluation of upper arm motor control in a subject affected by polyradiculoneuropathy 189
P3.13C.09 First-Line Treatments for Advanced Pure Large Cell Neuroendocrine Tumors (LCNEC):Insights from a Global Clinico-Genomic Study 185
QUALITY ASSURANCE FOR CLINICAL PRACTICE IN CERVICAL CANCER BRACHYTHERAPY WITH IR-192 SOURCE: IN VIVO DOSIMETRY WITH QED DIODES 184
Disclosing 3D Shape of Ossa Genitalia in Primates 183
Adipokines: The Missing Link between Alzheimer's Disease and Type 2 Diabetes? 182
602 Frequent Epigenetic Inactivation of KEAP1 Gene in Breast Cancer 182
112P Measuring time-toxicity and prognostic impact of hospital attendance in early phase cancer trials participants 180
Does HE4 have a role in the recurrence of ovarian cancer? 180
Delayed surgery after radio-chemotherapy for rectal adenocarcinoma is protective for anastomotic dehiscence: a single centre retrospective analysis 180
METAL HOMEOSTASIS IN PATIENTS WITH PORTO-SYSTEMIC ENCEPHALOPATHY 180
Chronotherapy and surgery for unresectable hepatic metastases from colorectal cancer 179
Postoperative Serum Procalcitonin to Predict Clinically Relevant Pancreatic Fistula after Pancreatoduodenectomy 178
Early opioid exposure (EOE) and impaired efficacy in patients with advanced NSCLC treated with PD-L1 inhibition: A pooled post hoc analysis of the POPLAR and OAK trials 176
Risultati preliminari dell’uso della risonanza magnetica nello studio dei disturbi dell’evacuazione 175
AB0550 PHENOTYPE OF BIOPSY-PROVEN PATIENTS WITH PRIMARY SJÖGREN SYNDROME LACKING RO AUTOANTIBODIES: HIGH FREQUENCY OF DRYNESS SYMPTOMS WITH LOW SYSTEMIC ACTIVITY (BIG DATA SJÖGREN PROJECT) 175
1065P Dose dependent detrimental effect of baseline pantoprazole on clinical outcomes from first-line chemo-ICI regimens in patients with advanced stage NSCLC 174
APPLICATION OF RADIOFREQUENCY INTERSTITIAL TUMOR ABLATION(RITA) IN "NO CLAMP-NO SUTURE" LAPAROSCOPIC PARTIAL NEPHRECTOMY 173
Aligned electrospun poly-l-lactide fibers for tendon regeneration: a preliminary in vitro study 173
Diagnosis of labour: the II prospective clinical study 171
BREATH PRINT ANALYSIS BY E-NOSE IS ASSOCIATED WITH ADVERSE OUTCOMES OF CIRRHOTIC PATIENTS INDEPENDENTLY FROM THE OTHER PROGNOSTIC INDICES 170
3D Bioprinting of Human Skin and Squamous Cell Tumors (SCCs) as Advanced Models for Precision Medicine (BIOSQIN) 168
Gait Speed Is a Valid Indicator in the Assessment of Perioperative Risk in the Elderly Surgical Patient 168
Assessment of liver function by the exhaled breath-print during chronic liver disease 166
PLASTIC IN PLACENTA: WHAT IS IT? WHAT TO DO? 164
1352P Real-world second-line outcomes of NSCLC patients receiving first-line chemotherapy plus immunotherapy 162
EP24.13: Fetomaternal hemorrhage: a new hypothesis on the importance of fetal vasoconstriction – a case report 162
CARBOPLATINUM IN NEOADJUVANT CHEMOTHERAPY FOR LOCALLY ADVANCED CERVICAL CANCER: A PILOT STUDY. 162
Biomimetic Polyurethane Scaffolds Guiding the In Vitro Behavior of Cardiac Stem Cells 161
Hepatic Artery Anomaly Does Not Impact Pancreatoduodenectomy Outcomes: A Matched Pair Analysis 154
Aberrant expression of IL-22RA1 on hematopoietic cells as immunologically signature of primary sjogren’s syndrome and sjogren-associated non-hodgkin lymphomas 151
AB0458 A PHASE II RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PROOF OF CONCEPT STUDY OF ORAL SELETALISIB IN PATIENTS WITH PRIMARY SJÖGREN’S SYNDROME (PSS) 151
1-year results of the subclavian access for tavi with the corevalve bioprosthesis in 132 consecutive patients 138
The Hendrich II model for assessing the risk of falls for hospitalized patients [Il modello Hendrich II per la valutazione del rischio di cadute per pazienti ospedalizzati] 135
THU-390 - Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 122
18F-CHOLINE PET/CT FOR EARLY DETECTION OF PROSTATE CANCER RECURRENCE AFTER RADICAL PROSTATECTOMY. 120
Cerebral Hemodynamics, Patent foramen ovale and White Matter Hyperintensities in patients Migraine with aura, young stroke patients and controls 113
18F-CHOLINE PET/CT FOR EARLY DETECTION OF PROSTATE CANCER RECURRENCE AFTER RADICAL PROSTATECTOMY 111
Abruptio placenta and TLRs 2-3-4 110
Prospective observational multicentric case-control study about 'fatigue' in patients with history of breast cancer 100
42P Radiation induced pneumonitis in the era of the COVID-19 pandemic: Artificial intelligence for differential diagnosis 100
534 Determinants of 5-year survival in patients with advanced NSCLC with PD-L1 ≥50% treated with first line pembrolizumab outside of clinical trials: results from the Pembro-real 5Y global registry 97
GH-resistance in different stages of chronic liver disease 96
The ability of Lung High-Resolution Computed Tomography Severity Score to early identify COVID-19 patients who need respiratory support. A retrospective analysis of a monocentric Italian COVID-19 cohort 93
A case of synchronous hepatic and gastric malignancies: diagnostic problems and therapeutical strategies 93
35. Association of robot-assisted rehabilitation and non-invasive brain stimulation to improve upper limb function in chronic stroke patients 93
485 Impact of opioid signaling on the tumor microenvironment and clinical outcomes in patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICIs) 92
ASSESSING PRO-INFLAMMATORY PROPERTIES OF H-FERRITIN BY EX VIVO AND IN VITRO OBSERVATIONS 90
"NO CLAMP NO SUTURE'' LAPAROSCOPIC PARTIAL NEPHRECTOMY FOR SMALL EXOPHYTIC RENAL TUMORS 89
Afatinib, an irreversible ErbB family inhibitor, demonstrates activity against HER2 mutated cervical cancer in vitro 88
A polysaccharide foam-like scaffold obtained by crosslinking lactose-modified chitosan and oxidized hyaluronan 88
Abstract P5-04-13: Antibody-based therapy targeting integrin a5 is an effective strategy to treat experimental breast cancer bone metastasis 88
Baccalaureate nursing students’ attitudes towards old people 87
Chemokines and Inflammatory Mediators in Erosive Esophagitis (EE) Compared to Non-Erosive Reflux Disease (NERD) and Control Patients 87
Biological effects of cabozantinib on osteosarcoma-bone microenvironment model 87
A Systematic Review of the Role of Lymphadenectomy in Pancreatic Cancer 86
Alimentazione e gravidanza fisiologica 86
Assessment of renal damage following warm ischemia time during LPN: results of a prospective study 86
EBUS-TBNA, EUS-FNA or EUS-B-FNA for mediastinal staging of lung cancer: A purpose of diagnostic algorithm 85
A randomized phase II study assessing an optimized schedule of oregovomab (0) anti-CA1 25 vaccination with carboplatin paclitaxel (CP) relative to CP alone in front-line treatment of optimally cytoreduced stage III/IV ovarian cancer (EOC) 85
Biological effects of cabozantinib on bone microenvironment 85
Body Mass Index and Impaired Fasting Blood Glucose as Predictive Factors of Efficacy in Cetuximab-Based Colorectal Cancer Treatment 85
A meta-synthesis of experiences of caregivers of people with COPD. 84
LPS AND RADIATION-INDUCED GUT PERMEABILITY DAMAGE: FOCUS ON THE POTENTIAL BENEFICIAL EFFECT OF GRAPE SEED EXTRACT 83
Amniotic membrane transplantation associated with conjunctival peritomy in the management of Mooren's ulcer. 83
THU-464 aMAP score predicts progression-free survival in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma 83
Integrated treatment of pancreatic head carcinoma 82
Different Levels of Alkaline Phospatase (ALP) in Multiple Myeloma (MM) and SOLID Tumors with BONE Lesions 82
A New Technique for Laparoscopic Stripping of Endometriomas: FloSeal Hemostatic Agent for Hemostasis of the Ovarian Wall 81
). IL-6 e TGF-b1 nel siero e nei sovranatanti di cellule mononucleate in pazienti con sclerosi sistemica (SSC). 81
Long non-coding RNA HSAT II as a new biomarker for the identification of high risk intraductal papillary mucinous neoplasms (IPMNs). 81
Amniotic membrane produces and releases nerve growth factor (NGF) and expresses NGF receptors 80
5-YEAR ONCOLOGIC OUTCOMES FOR ROBOT-ASSISTED AND LAPAROSCOPIC PARTIAL NEPHRECTOMY FOR HIGH-RISK RENAL TUMORS 80
66 ABERRANT GENES PROMOTER METHYLATION IN NEURAL-CREST DERIVED TUMOURS 80
35 DNA DOUBLE STRANDS BREAK REPAIR GENES EXPRESSION ANALYSIS REVEAL RAD51 AS A NEW POTENTIAL BIOMARKER IN BREAST CANCER. 80
706. DNA Vaccine Strategy Against Chronic B-Cell Lymphoma: Anti-Idiotypic CDR3 Vaccination 79
METAL METABOLISM IMPAIRMENT IN PATIENTS WITH HEPATIC ENCEPHALOPATHY 79
Continent ileocolonic urinary diversion (rome pouch) for gynecologic malignancies: techniqueand feasibility. 79
ALT levels are associated with metabolic parameters and age in a large real-life population. 79
OS-078-YI Hepatic decompensation as an aetiology-dependent determinant of mortality in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab 77
Combined multimodality treatment of primary or recurrent locally advanced rectal cancer 77
ECONOMIC IMPACT AMONG FAMILY CAREGIVERS OF ADVANCED OVARIAN CANCER PATIENTS 76
45 GENE EXPRESSION OF SOMATOSTATIN RECEPTOR SUBTYPES SSTR2a, SSTR3 AND SSTR5 IN PERIPHERAL BLOOD OF NEUROENDOCRINE LUNG CANCER AFFECTED PATIENTS 76
Clinical outcomes and post-progression retreatment in patients with metastatic NSCLC who complete two years of treatment with immune checkpoint blockade 75
"NO CLAMPING-NO SUTURING" LAPAROSCOPIC PARTIAL NEPHRECTOMY (LPN). 73
Adjuvant external and intraoperative radiation therapy in resectable pancreatic cancer 73
EVIDENCE FOR REDUCED ANGIOGENESIS IN BONE MARROW (BM) IN SYSTEMIC SCLEROSIS (SSC) 70
Aberrant cytokine expression and severity of the infiltrates are reverted by rituximab therapy in salivary glands of patients with Sjogren’s syndrome 68
T.07.3: CHARACTERISTICS AND OUTCOMES OF IMMUNOTHERAPYRELATED LIVER INJURY IN PATIENTS WITH HEPATOCELLULAR CARCINOMA COMPARED TO PATIENTS WITH ADVANCED SOLID TUMOURS 66
Association between clinical, histopathological and molecular features in primary Sjogren's Syndrome: a retrospective study 66
Drug releasing hybrid scaffold: new avenue in cardiovascular tissue engineering 64
Different HLA pattern in patients affected by LADA in Congo, central Africa 57
Totale 12.369
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022709 0 0 11 6 57 8 6 3 24 32 13 549
2022/2023387 29 11 8 32 43 26 33 22 24 35 108 16
2023/20241.861 82 165 76 114 203 826 33 84 22 136 35 85
2024/202515.437 230 198 624 65 107 344 220 69 1.268 1.174 5.235 5.903
2025/2026314 314 0 0 0 0 0 0 0 0 0 0 0
Totale 18.708